Overview

Injection Pen Market Introduction:

Injection Pen Market is estimated to value over USD 49 billion by 2027 end and register a CAGR of over 5.7% during the forecast period 2020 to 2027.

Injection pens are prefilled syringes that are used to administer drugs into the body. They are commonly used to dispense insulin to diabetic patients as well as for fertility and therapy treatments. They have a number of advantages, namely because they are different from the regular syringe and vial usage. The simple handling, application and maintenance are factors which shall augment the global injection pen market growth further.

The demand for injection pens is anticipated to gain significant traction in the market due to the growing presence of chronic diseases on a global scale, a rise in approvals and sanctions by regulatory bodies, as well as considerable reimbursements. However, the tendency to opt for alternative drug delivery methods and the relatively low reimbursement in developing nations, are factors which could pose hindrances to the market. 

The disposable injection pens market is expected to account for the highest CAGR during the forecast time frame. Factors such as user-friendliness, portability and a reduced possibility of infection, is likely to spur the market growth. Going by the basis of therapy, the market for injection pens is divided into, growth hormone therapy, diabetes, fertility, osteoporosis, and other therapies. The high growth of the injection pen segment can be linked to the large population pool and profound reimbursements for diabetes related treatments in developed nations. The diabetes segment is then categorized into GLP-1and insulin.

Major players in the global injection pen market are:

Ypsomed (Switzerland), Sanofi (France), Owen Mumford (UK), Haselmeier (Switzerland), Merck (US), Becton Dickinson and Company (US), Eli Lilly (US), F.Hoffman-La Roche (Switzerland), AstraZeneca (UK), Pfizer (US), Novartis (Switzerland).

Injection Pen Market Segmentation:

By Type

  • Disposable Injection Pen
  • Reusable Injection Pen               

By Application

  • Diabetes
  • Insulin
  • Non-insulin
  • Anaphylaxis
  • Osteoporosis
  • Growth hormone deficiency
  • Arthritis
  • Fertility
  • Others     

By End User

  • Home Care
  • Hospitals & Clinics  

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the global injection pen market by dosage type, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: 
sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics